Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 23 Sept 2026 for Gilead Sciences, INC., €102k.
Filing timeline
BuySaleErin Burkhart
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Erin Burkhart: trading record in brief
Erin Burkhart, GVP, Chief Accounting Officer at Biomarin Pharmaceutical Inc, appears in 14 of the record's 16 filings; the other 2 are at Gilead Sciences, Inc., as SVP, Controllership. They were published between May 18, 2022 and September 23, 2026.
The record holds 10 grants, 5 sales and 1 option exercise, with no purchase. The sales total EUR 516,210, with a median of EUR 87,737: EUR 191,534 on April 10, 2024, EUR 93,841 on May 20, 2025 and EUR 87,737 on February 24, 2025.
The yearly pace runs from 1 filing in 2022 to 6 in 2025, with 5 in 2024 and 2 in 2023 and 2026. Two filings fall in the last twelve months, with no purchase and no sale. The median publication delay is 2 days.
At Biomarin, 2 of Burkhart's own market trades fall within 30 days of a trade by Charles Greg Guyer, and 1 of each of Cristin Hubbard, George Eric Davis, Jean Jacques Bienaime and Jeffrey Robert Ajer, all on the same side.
Companies and markets linked to Erin Burkhart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
768 shares@ US$152.670.0001% mcap100.0% of flowCommon StockSEC:0001927648-26-000005:1
2,223 sharesCommon StockSEC:0001927648-26-000005:0
1,786 shares@ US$59.3111.9% of flowCommon StockSEC:0001048477-25-000060:1
996 shares@ US$59.277.9% of flowCommon StockSEC:0001048477-25-000060:0
1,295 shares@ US$71.5212.7% of flowCommon StockSEC:0001048477-25-000041:0
5,970 shares0Common StockSEC:0001048477-25-000039:1
823 shares@ US$69.447.9% of flowCommon StockSEC:0001048477-25-000039:0
1,344 shares@ US$68.3813.2% of flowCommon StockSEC:0001048477-25-000009:0
714 shares@ US$90.008.8% of flowCommon StockSEC:0001048477-24-000128:0
993 shares@ US$76.9710.6% of flowCommon StockSEC:0001048477-24-000084:0
2,286 shares@ US$90.0028.8% of flowCommon StockSEC:0001048477-24-000061:0
372 shares@ US$83.873.6% of flowCommon StockSEC:0001048477-24-000050:1
4,720 shares0Common StockSEC:0001048477-24-000050:0
796 shares@ US$92.0210.1% of flowCommon StockSEC:0001209191-23-030736:0
3,760 shares0Common StockSEC:0001567619-23-005287:0
11,130 shares0Common StockSEC:0001567619-22-011218:0
16 of 16 declarations
